2bkz: Difference between revisions

@@ Line 1: / Line 1: @@
-[[Image:2bkz.gif|left|200px]]
+{{Seed}}
+[[Image:2bkz.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2bkz|  PDB=2bkz  |  SCENE=  }}
-'''STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611'''
+===STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611===
-==Overview==
+<!--
-The synthesis and the preliminary expansion of this new class of CDK2 inhibitors are presented. The synthesis was accomplished using a solution-phase protocol amenable to rapid parallel expansion and suitable to be scaled-up in view of possible lead development. Following a medicinal chemistry program aimed at improving cell permeability and selectivity, a series of compounds with nanomolar activity in the biochemical assay and able to efficiently inhibit tumor cell proliferation has been obtained.
+The line below this paragraph, {{ABSTRACT_PUBMED_15713378}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 15713378 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_15713378}}
 ==About this Structure==
@@ Line 46: / Line 50: @@
 [[Category: Serine/threonine-protein kinase]]
 [[Category: Transferase]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 20:26:06 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 18:13:24 2008''

Navigation menu